HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xingxing Wang Selected Research

Lipids

1/2024Synthesis and biological evaluation of the novel chrysin prodrug for non-alcoholic fatty liver disease treatment.
8/2023Chrysin prevents inflammation-coinciding liver steatosis via AMPK signalling.
3/2018Serum lipid feature and potential biomarkers of lethal ventricular tachyarrhythmia (LVTA) induced by myocardial ion channel diseases: a rat model study.
1/2017Common lipid features of lethal ventricular tarchyarrhythmias (LVTAs) induced by myocardial infarction and myocardial ion channel diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xingxing Wang Research Topics

Disease

29Neoplasms (Cancer)
02/2024 - 04/2014
9Spinal Cord Injuries (Spinal Cord Injury)
01/2022 - 11/2006
6Infections
05/2024 - 05/2012
4Breast Neoplasms (Breast Cancer)
12/2023 - 07/2014
4Hypoxia (Hypoxemia)
01/2023 - 01/2017
3Fibrosis (Cirrhosis)
01/2024 - 01/2022
3Prostatic Neoplasms (Prostate Cancer)
01/2022 - 12/2014
3Carcinogenesis
01/2022 - 04/2014
3Wounds and Injuries (Trauma)
01/2022 - 08/2014
3Crush Injuries
11/2016 - 09/2012
3Hepatocellular Carcinoma (Hepatoma)
01/2015 - 01/2014
3Contusions
12/2014 - 01/2009
2Liver Neoplasms (Liver Cancer)
02/2024 - 06/2014
2Choroidal Neovascularization
02/2024 - 10/2023
2Non-alcoholic Fatty Liver Disease
01/2024 - 08/2023
2Malaria
10/2023 - 01/2021
2Fatty Liver
08/2023 - 01/2023
2Atherosclerosis
01/2023 - 02/2009
2Heterotopic Ossification (Ectopic Ossification)
11/2022 - 10/2022
2Hypertrophy
11/2022 - 01/2022
2COVID-19
08/2022 - 01/2020
2Vascular Remodeling
01/2022 - 01/2021
2Esophageal Squamous Cell Carcinoma
01/2022 - 02/2021
2Hypertension (High Blood Pressure)
01/2021 - 01/2021
2Type 2 Diabetes Mellitus (MODY)
01/2021 - 12/2020
2Ovarian Neoplasms (Ovarian Cancer)
07/2019 - 04/2014
2Ischemia
03/2019 - 01/2016
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2015 - 07/2014
2Ganglion Cysts (Ganglion)
02/2015 - 03/2012
2Leukemia
01/2015 - 11/2014
2Acute Promyelocytic Leukemia
12/2014 - 06/2014
1Bacterial Infections (Bacterial Infection)
05/2024
1Placenta Accreta
04/2024
1Postoperative Pain
02/2024
1Retinal Neovascularization
02/2024
1Placenta Previa
02/2024
1Head and Neck Neoplasms (Head and Neck Cancer)
02/2024
1Intestinal Fistula
02/2024
1Pancreatic Fistula (Pancreatic Fistulas)
02/2024
1Postoperative Hemorrhage
02/2024
1Insulin Resistance
01/2024
1Hyperlipidemias (Hyperlipidemia)
01/2024
1Body Weight (Weight, Body)
01/2024

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
08/2023 - 11/2006
6Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2014
5Arsenic Trioxide (Trisenox)FDA Link
09/2015 - 06/2014
4LipidsIBA
01/2024 - 01/2017
4NADPH Oxidases (NAD(P)H oxidase)IBA
11/2022 - 01/2021
3artemisinin (artemisinine)IBA
10/2023 - 01/2021
3Peptides (Polypeptides)IBA
01/2023 - 02/2018
3Nogo ReceptorsIBA
01/2020 - 11/2006
3RNA (Ribonucleic Acid)IBA
01/2019 - 01/2017
3Ion Channels (Ion Channel)IBA
03/2018 - 01/2016
3glabridinIBA
05/2016 - 01/2014
2Oxygen (Dioxygen)IBA
02/2024 - 10/2023
2chrysinIBA
01/2024 - 08/2023
2Retinaldehyde (Retinal)IBA
01/2024 - 03/2012
21-phenyl-3,3-dimethyltriazene (PDT)IBA
12/2023 - 07/2021
2VaccinesIBA
01/2023 - 08/2022
2EchinomycinIBA
01/2023 - 01/2023
2Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2021
2Methionine (L-Methionine)FDA Link
01/2023 - 01/2023
2Cysteine (L-Cysteine)FDA Link
01/2023 - 10/2016
2Interleukin-6 (Interleukin 6)IBA
01/2023 - 11/2016
2LigandsIBA
01/2023 - 01/2020
2potassium channel protein TREK-1IBA
01/2023 - 01/2023
2Immunologic Factors (Immunomodulators)IBA
11/2022 - 10/2022
2alpha-2-HS-GlycoproteinIBA
11/2022 - 10/2022
2Small Interfering RNA (siRNA)IBA
05/2022 - 07/2021
2Sirolimus (Rapamycin)FDA Link
01/2022 - 03/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2017
2Cisplatin (Platino)FDA LinkGeneric
01/2022 - 07/2014
2SolutionsIBA
01/2022 - 01/2021
2Cystatin BIBA
07/2019 - 04/2014
2Messenger RNA (mRNA)IBA
07/2019 - 04/2014
2DNA (Deoxyribonucleic Acid)IBA
11/2016 - 09/2015
2PhytochemicalsIBA
11/2016 - 05/2016
2stearic acid (magnesium stearate)FDA LinkGeneric
10/2016 - 01/2016
2Nogo Receptor 1IBA
12/2014 - 11/2006
2Transforming Growth Factor beta (TGF-beta)IBA
12/2014 - 01/2014
1Anti-Bacterial Agents (Antibiotics)IBA
05/2024
1ProdrugsIBA
01/2024
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2024
1FlavonoidsIBA
01/2024

Therapy/Procedure

12Therapeutics
01/2024 - 11/2006
3Immunotherapy
05/2024 - 01/2022
3Lasers (Laser)
02/2024 - 10/2023
2Operative Time
04/2024 - 02/2024
2Microspheres (Microsphere)
02/2024 - 02/2015
2Cesarean Section (Caesarean Section)
02/2024 - 01/2023
2Neoadjuvant Therapy
02/2021 - 01/2015
2Axotomy
06/2019 - 09/2012
1Conservative Treatment
04/2024
1Hysterectomy
04/2024
1Blood Transfusion (Blood Transfusions)
04/2024
1Pain Management
02/2024
1Pancreaticoduodenectomy
02/2024
1Length of Stay
02/2024
1Lymph Node Excision (Lymph Node Dissection)
02/2024
1Oral Administration
01/2024